Kwang Dong Pharmaceutical Statistics
Total Valuation
KRX:009290 has a market cap or net worth of KRW 224.29 billion. The enterprise value is 341.39 billion.
Market Cap | 224.29B |
Enterprise Value | 341.39B |
Important Dates
The next estimated earnings date is Tuesday, March 18, 2025.
Earnings Date | Mar 18, 2025 |
Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
KRX:009290 has 39.28 million shares outstanding. The number of shares has decreased by -1.58% in one year.
Current Share Class | n/a |
Shares Outstanding | 39.28M |
Shares Change (YoY) | -1.58% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 12.95% |
Owned by Institutions (%) | 27.20% |
Float | 32.24M |
Valuation Ratios
The trailing PE ratio is 6.76.
PE Ratio | 6.76 |
Forward PE | n/a |
PS Ratio | 0.14 |
PB Ratio | 0.40 |
P/TBV Ratio | 0.42 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.60, with an EV/FCF ratio of -4.49.
EV / Earnings | 10.08 |
EV / Sales | 0.21 |
EV / EBITDA | 8.60 |
EV / EBIT | 13.07 |
EV / FCF | -4.49 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.47.
Current Ratio | 1.41 |
Quick Ratio | 0.97 |
Debt / Equity | 0.47 |
Debt / EBITDA | 7.26 |
Debt / FCF | -3.84 |
Interest Coverage | 2.85 |
Financial Efficiency
Return on equity (ROE) is 5.91% and return on invested capital (ROIC) is 2.00%.
Return on Equity (ROE) | 5.91% |
Return on Assets (ROA) | 1.52% |
Return on Invested Capital (ROIC) | 2.00% |
Return on Capital Employed (ROCE) | 3.97% |
Revenue Per Employee | 1.57B |
Profits Per Employee | 32.51M |
Employee Count | 1,042 |
Asset Turnover | 1.49 |
Inventory Turnover | 6.78 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.70% in the last 52 weeks. The beta is 0.42, so KRX:009290's price volatility has been lower than the market average.
Beta (5Y) | 0.42 |
52-Week Price Change | -26.70% |
50-Day Moving Average | 5,564.80 |
200-Day Moving Average | 6,043.20 |
Relative Strength Index (RSI) | 60.75 |
Average Volume (20 Days) | 44,304 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:009290 had revenue of KRW 1.63 trillion and earned 33.87 billion in profits. Earnings per share was 844.84.
Revenue | 1.63T |
Gross Profit | 296.60B |
Operating Income | 26.70B |
Pretax Income | 51.60B |
Net Income | 33.87B |
EBITDA | 40.27B |
EBIT | 26.70B |
Earnings Per Share (EPS) | 844.84 |
Balance Sheet
The company has 218.26 billion in cash and 292.33 billion in debt, giving a net cash position of -74.07 billion or -1,885.54 per share.
Cash & Cash Equivalents | 218.26B |
Total Debt | 292.33B |
Net Cash | -74.07B |
Net Cash Per Share | -1,885.54 |
Equity (Book Value) | 616.67B |
Book Value Per Share | 14,311.99 |
Working Capital | 207.96B |
Cash Flow
In the last 12 months, operating cash flow was -11.41 billion and capital expenditures -64.63 billion, giving a free cash flow of -76.04 billion.
Operating Cash Flow | -11.41B |
Capital Expenditures | -64.63B |
Free Cash Flow | -76.04B |
FCF Per Share | -1,935.91 |
Margins
Gross margin is 18.15%, with operating and profit margins of 1.63% and 2.07%.
Gross Margin | 18.15% |
Operating Margin | 1.63% |
Pretax Margin | 3.16% |
Profit Margin | 2.07% |
EBITDA Margin | 2.46% |
EBIT Margin | 1.63% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.75%.
Dividend Per Share | 100.00 |
Dividend Yield | 1.75% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 11.83% |
Buyback Yield | 1.58% |
Shareholder Yield | 3.33% |
Earnings Yield | 15.10% |
FCF Yield | -33.90% |
Stock Splits
The last stock split was on April 26, 1999. It was a forward split with a ratio of 5.
Last Split Date | Apr 26, 1999 |
Split Type | Forward |
Split Ratio | 5 |
Scores
KRX:009290 has an Altman Z-Score of 2.56. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.56 |
Piotroski F-Score | n/a |